Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology

计划入组 1,500 人 · 首次发布于 2020 年 12 月 1 日

Protein and Satiety in Older Adults (PROSAT)

计划入组 38 人 · 首次发布于 2022 年 8 月 19 日

Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

计划入组 53 人 · 首次发布于 2015 年 10 月 8 日

PRT-002(Protai)

PRT-003

PAI-CPD-1

Protara Therapeutics

United States

Protalix Biotherapeutics

Israel

PROTALIX LTD.

Israel

Protai Advances AI-Driven Drug Discovery with Novel TNFα Targeting and Protein Degradation Technologies

PROTAC Protein Degraders Enter Phase 3 Trials, Targeting 'Undruggable' Proteins

Targeted Protein Degradation Emerges as Multi-Billion Dollar Therapeutic Frontier with First PROTAC Approval Expected in 2026